Researchers question whether there is substance to the US Food and Drug Agency’s recent warning that statins could affect the memory, attention span and other cognitive abilities of people who take this drug to control high cholesterol.
This follows a systematic review of 25 clinical trials incorporating nearly 47,000 people. It was led by Brian R. Ott, MD, director of The Alzheimer’s Disease & Memory Disorders Center at Rhode Island Hospital and professor at the Alpert Medical School of Brown University in the U.S. The review findings appear in the Journal of General Internal Medicine, published by Springer.
READ FULL ARTICLE From Medical News Today